Prevalence and factors associated with left ventricular remodeling in renal artery stenosis

Journal of the American Society of Hypertension

Volumn 8, Issue 4, 2014, Pages 254-261

  Khan, Abdur Rahman ^a   Sheikh, Mujeeb ^a   Kaw, Dinkar ^a   Cooper, Christopher J ^a   Khouri, Samer J ^a  

^a UNIVERSITY OF TOLEDO MEDICAL CENTER   (United States)

Author keywords

left ventricular hypertrophy; Left ventricular remodeling; renal artery stenosis

Indexed keywords

AGED; ARTICLE; BLOOD VESSEL PARAMETERS; BLOOD VESSEL WALL; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR PARAMETERS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; ECCENTRIC HYPERTROPHY; FEMALE; GLOMERULUS FILTRATION RATE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART VENTRICLE REMODELING; HUMAN; KIDNEY ARTERY STENOSIS; KIDNEY FAILURE; LEFT VENTRICULAR MASS INDEX; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RELATIVE WALL THICKNESS; SYSTOLIC BLOOD PRESSURE; VASCULAR STENT; ECHOCARDIOGRAPHY; ECHOGRAPHY; HYPERTROPHY, LEFT VENTRICULAR; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK FACTOR;

AGED; ECHOCARDIOGRAPHY; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; PREVALENCE; RENAL ARTERY OBSTRUCTION; RISK FACTORS; VENTRICULAR REMODELING;

EID: 84898900784     PISSN: 19331711     EISSN: 18787436     Source Type: Journal    
DOI: 10.1016/j.jash.2014.01.008     Document Type: Article

References (43)

1. M.S. Edwards, K.J. Hansen, T.E. Craven, A.J. Bleyer, G.L. Burke, and P.J. Levy et al. Associations between renovascular disease and prevalent cardiovascular disease in the elderly: a population-based study Vasc Endovascular Surg 38 2004 25 35
2. M.S. Edwards, T.E. Craven, G.L. Burke, R.H. Dean, and K.J. Hansen Renovascular disease and the risk of adverse coronary events in the elderly: a prospective, population-based study Arch Intern Med 165 2005 207 213
3. M. Johansson, H. Herlitz, G. Jensen, B. Rundqvist, and P. Friberg Increased cardiovascular mortality in hypertensive patients with renal artery stenosis. Relation to sympathetic activation, renal function and treatment regimens J Hypertens 17 1999 1743 1750
4. J.J. Beutler, J.M. Van Ampting, P.J. Van De Ven, H.A. Koomans, F.J. Beek, and A.J. Woittiez et al. Long-term effects of arterial stenting on kidney function for patients with ostial atherosclerotic renal artery stenosis and renal insufficiency J Am Soc Nephrol 12 2001 1475 1481
5. D.J. Kennedy, W.R. Colyer, P.S. Brewster, M. Ankenbrandt, M.W. Burket, and A.S. Nemeth et al. Renal insufficiency as a predictor of adverse events and mortality after renal artery stent placement Am J Kidney Dis 42 2003 926 935
6. G.C. Kane, N. Xu, E. Mistrik, T. Roubicek, A.W. Stanson, and V.D. Garovic Renal artery revascularization improves heart failure control in patients with atherosclerotic renal artery stenosis Nephrol Dial Transplant 25 2010 813 820
7. A. Losito, R.M. Fagugli, I. Zampi, B. Parente, P. de Rango, and G. Giordano et al. Comparison of target organ damage in renovascular and essential hypertension Am J Hypertens 9 1996 1062 1067
8. S. Yusuf, P. Sleight, J. Pogue, J. Bosch, R. Davies, and G. Dagenais Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators N Engl J Med 342 2000 145 153
9. E.M. Lonn, S. Yusuf, P. Jha, T.J. Montague, K.K. Teo, and C.R. Benedict et al. Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection Circulation 90 1994 2056 2069
10. M. Johansson, M. Elam, B. Rundqvist, G. Eisenhofer, H. Herlitz, and G. Lambert et al. Increased sympathetic nerve activity in renovascular hypertension Circulation 99 1999 2537 2542
11. Y. Higashi, S. Sasaki, K. Nakagawa, H. Matsuura, T. Oshima, and K. Chayama Endothelial function and oxidative stress in renovascular hypertension N Engl J Med 346 2002 1954 1962
12. K.E. Teunissen, C.T. Postma, B.C. van Jaarsveld, F.H. Derkx, and T. Thien Endothelin and active renin levels in essential hypertension and hypertension with renal artery stenosis before and after percutaneous transluminal renal angioplasty J Hypertens 15 1997 1791 1796
13. A. Meyrier [Vascular mechanisms of renal fibrosis. Vasculonephropathies and arterial hypertension] Bull Acad Natl Med 183 1999 33 45 discussion 45-6
14. J.R. Wright, A.E. Shurrab, A. Cooper, P.R. Kalra, R.N. Foley, and P.A. Kalra Left ventricular morphology and function in patients with atherosclerotic renovascular disease J Am Soc Nephrol 16 2005 2746 2753
15. A.T. Hirsch, Z.J. Haskal, N.R. Hertzer, C.W. Bakal, M.A. Creager, and J.L. Halperin et al. ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation J Am Coll Cardiol 47 2006 1239 1312
16. A. Uehata, T. Matsuguchi, J. Bittl, J. Orav, and Meredith Accuracy of electronic digital calipers compared with quantitative angiography in measuring coronary arterial diameter Circulation 88 1993 1724 1729
17. D.W. Cockcroft, and M.H. Gault Prediction of creatinine clearance from serum creatinine Nephron 16 1976 31 41
18. J.T. Wright, G. Bakris, and T. Greene et al. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease JAMA 288 2002 2421 2431
19. R.V. Luepker, F.S. Apple, and R.H. Christenson et al. Case definitions for acute coronary heart disease in epidemiology and clinical research studies: a statement from the AHA Council on Epidemiology and Prevention; AHA Statistics Committee; World Heart Federation Council on Epidemiology and Prevention; the European Society of Cardiology Working Group on Epidemiology and Prevention; Centers for Disease Control and Prevention; and the National Heart, Lung, and Blood Institute Circulation 108 2003 2543 2549
20. P.A. McKee, W.P. Castelli, P.M. McNamara, and W.B. Kannel The natural history of congestive heart failure: the Framingham study N Engl J Med 285 1971 1441 1446
21. R.M. Lang, M. Bierig, and R.B. Devereux et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology J Am Soc Echocardiogr 18 2005 1440 1463
22. R. Devereux, and N. Reichek Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method Circulation 55 1977 613 618
23. A. Ganau, R. Devereux, and M. Roman et al. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension J Am Coll Cardiol 19 1992 1550 1558
24. K.U. Eckardt, A. Scherhag, and I.C. Macdougall et al. Left ventricular geometry predicts cardiovascular outcomes associated with anemia correction in CKD J Am Soc Nephrol 20 2009 2651 2660
25. M.P. Bayauli, F.B. Lepira, P.K. Kayembe, and J.R. M'Buyamba-Kabangu Left ventricular hypertrophy and geometry in type 2 diabetes patients with chronic kidney disease. An echocardiographic study Cardiovasc J Afr 23 2012 73 77
26. F. Afshinnia, S. Spitalewitz, S.Y. Chou, D.Z. Gunsburg, and H.L. Chadow Left ventricular geometry and renal function in hypertensive patients with diastolic heart failure Am J Kid Dis 49 2007 227 236
27. T. Zeller, A. Rastan, and U. Schwarzwalder et al. Regression of left ventricular hypertrophy following stenting of renal artery stenosis J Endovasc Ther 14 2007 189 197
28. Y. Yoshitomi, T. Nishikimi, and H. Abe et al. Comparison of changes in cardiac structure after treatment in secondary hypertension Hypertension 27 1996 319 323
29. M.A. Corriere, J.R. Hoyle, and T.E. Craven et al. Changes in left ventricular structure and function following renal artery revascularization Ann Vasc Surg 24 2010 80 84
30. J. Mathew, P. Sleight, and E. Lonn et al. Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril Circulation 104 2001 1615 1621
31. P.A. Kalra, H. Guo, and A.T. Kausz et al. Atherosclerotic renovascular disease in United States patients aged 67 years or older: risk factors, revascularization, and prognosis Kidney Int 68 2005 293 301
32. J.R. Wright, A.E. Shurrab, A. Cooper, P.R. Kalra, R.N. Foley, and P.A. Kalra Progression of cardiac dysfunction in patients with atherosclerotic renovascular disease QJM 102 2009 695 704
33. P.H. Sugden Mechanotransduction in cardiomyocyte hypertrophy Circulation 103 2001 1375 1377
34. C.P. Baines, and J.D. Molkentin STRESS signaling pathways that modulate cardiac myocyte apoptosis J Mol Cell Cardiol 38 2005 47 62
35. K. Zhang, J. Chen, Y. Liu, T. Wang, and L. Wang et al. Diastolic blood pressure reduction contributes more to the regression of left ventricular hypertrophy: a meta-analysis of randomized controlled trials J Hum Hypertens 27 2013 698 706
36. L.H. Opie, P.J. Commerford, B.J. Gersh, and M.A. Pfeffer Controversies in ventricular remodelling Lancet 367 2006 356 367
37. I. Mimura, H. Nishi, N. Mise, M. Mori, and T. Sugimoto Left ventricular geometry and cardiovascular mortality based on haemodialysis patient autopsy analyses Nephrology 15 2010 549 554
38. C.J. Lavie, R.V. Milani, D. Patel, S.M. Artham, and H.O. Ventura Disparate effects of obesity and left ventricular geometry on mortality in 8088 elderly patients with preserved systolic function Postgrad Med 121 2009 119 125
39. A. Verma, A. Meris, and H. Skali et al. Prognostic implications of left ventricular mass and geometry following myocardial infarction: the VALIANT (VALsartan In Acute myocardial iNfarcTion) Echocardiographic Study JACC Cardiovasc Imaging 1 2008 582 591
40. M.A. Konstam, J.E. Udelson, I.S. Anand, and J.N. Cohn Ventricular remodeling in heart failure: a credible surrogate endpoint J Card Fail 9 2003 350 353
41. M.F. Stoddard, A.C. Pearson, M.J. Kern, J. Ratcliff, D.G. Mrosek, and A.J. Labovitz Influence of alteration in preload on the pattern of left ventricular diastolic filling as assessed by Doppler echocardiography in humans Circulation 79 1989 1226 1236
42. F. Grothues, G.C. Smith, and J.C. Moon et al. Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy Am J Cardiol 90 2002 29 34
43. M.A. Hlatky, P. Greenland, and D.K. Arnett et al. Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association Circulation 119 2009 2408 2416